All Regions and All Sectors

On Monday’s (12/03/18) news briefing with BBC World News, OBG Editor-in-Chief Oliver Cornock discussed the delay in Saudi Aramco’s IPO, Saudi crown prince’s visit to the UK and what it means for investors.

On Monday’s (29/01/18) news briefing with BBC World News, OBG Editor-in-Chief Oliver Cornock discussed the fall in business optimism with growing Brexit uncertainty, growth in the global economy, the challenges of automation in the UK’s labour market, and more.

On Monday’s (07/11/17) news briefing with BBC World News, OBG Editor-in-Chief Oliver Cornock discussed the divided overview of Brexit progress, increasing concerns over North Korea’s security threat and how investors are reacting to warning signs shown in the global economy.

On Tuesday’s (07/11/17) news briefing with BBC World News, OBG Editor-in-Chief Oliver Cornock discussed the plunge in snapchat’s stock prices due to weak revenue and user growth, the influence of Trump’s current Asia tour on US-china ties. The review also discussed the aid blockade in Yemen, slow Brexit progress warning and driver-less cars

On Tuesday’s (10/10/17) newspaper review with BBC World News, OBG Editor-in-Chief Oliver Cornock discussed the potential risk of Britain’s exit from the EU without a deal, the speculation surrounding the Catalan leadership’s speech on Tuesday evening, and growing fears of conflict over Kirkuk. The review also discussed the global cost of obesity, plus much more.

On Monday’s (07/08/17) newspaper review with BBC World News, OBG Editor-in-Chief Oliver Cornock discussed China’s vow to support the United Nations’ curb on North Korea to end provocation, the released memo by a Google staff member claiming an anti-diverse organisational culture. The review also discussed the decline of retail stores in the US as e-commerce sales grow, plus much more.

On Thursday’s (27/07/17) newspaper review with BBC World News, OBG Editor-in-Chief Oliver Cornock discussed Trump’s ban on transgender service members in the U.S military, GlaxoSmithKline’s plan to cut costs and Amazon hitting $500 billion in market capitalisation. The review also discussed new research on antibiotics usage, plus much more.